DK3033104T3 - Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab - Google Patents

Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab Download PDF

Info

Publication number
DK3033104T3
DK3033104T3 DK14836725.3T DK14836725T DK3033104T3 DK 3033104 T3 DK3033104 T3 DK 3033104T3 DK 14836725 T DK14836725 T DK 14836725T DK 3033104 T3 DK3033104 T3 DK 3033104T3
Authority
DK
Denmark
Prior art keywords
forequartered
ecospiratory
astmatics
benralizumab
procedures
Prior art date
Application number
DK14836725.3T
Other languages
Danish (da)
English (en)
Inventor
Donald Raible
Christine Ward
Lorin Roskos
Bing Wang
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK3033104T3 publication Critical patent/DK3033104T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Endocrinology (AREA)
DK14836725.3T 2013-08-12 2014-08-07 Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab DK3033104T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361864948P 2013-08-12 2013-08-12
PCT/US2014/050119 WO2015023507A2 (en) 2013-08-12 2014-08-07 Methods for increasing forced expiratory volume in asthmatics using benralizumab

Publications (1)

Publication Number Publication Date
DK3033104T3 true DK3033104T3 (da) 2019-06-17

Family

ID=52448838

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14836725.3T DK3033104T3 (da) 2013-08-12 2014-08-07 Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab
DK19158446.5T DK3520811T3 (da) 2013-08-12 2014-08-07 Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19158446.5T DK3520811T3 (da) 2013-08-12 2014-08-07 Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab

Country Status (26)

Country Link
US (1) US9441046B2 (cg-RX-API-DMAC7.html)
EP (5) EP3520811B1 (cg-RX-API-DMAC7.html)
JP (4) JP6746496B2 (cg-RX-API-DMAC7.html)
KR (1) KR102337599B1 (cg-RX-API-DMAC7.html)
CN (2) CN111588849A (cg-RX-API-DMAC7.html)
AU (2) AU2014306959B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016002317A8 (cg-RX-API-DMAC7.html)
CA (1) CA2917603C (cg-RX-API-DMAC7.html)
CY (2) CY1122033T1 (cg-RX-API-DMAC7.html)
DK (2) DK3033104T3 (cg-RX-API-DMAC7.html)
ES (2) ES2733602T3 (cg-RX-API-DMAC7.html)
HK (1) HK1222559A1 (cg-RX-API-DMAC7.html)
HR (2) HRP20190920T1 (cg-RX-API-DMAC7.html)
HU (2) HUE053627T2 (cg-RX-API-DMAC7.html)
LT (2) LT3033104T (cg-RX-API-DMAC7.html)
ME (1) ME03403B (cg-RX-API-DMAC7.html)
MX (2) MX381102B (cg-RX-API-DMAC7.html)
PL (2) PL3033104T3 (cg-RX-API-DMAC7.html)
PT (2) PT3033104T (cg-RX-API-DMAC7.html)
RS (2) RS58711B1 (cg-RX-API-DMAC7.html)
RU (1) RU2703568C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201600483QA (cg-RX-API-DMAC7.html)
SI (2) SI3033104T1 (cg-RX-API-DMAC7.html)
SM (2) SMT202100152T1 (cg-RX-API-DMAC7.html)
TR (1) TR201907907T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015023507A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014306956B2 (en) 2013-08-12 2019-11-21 Astrazeneca Ab Methods for reducing exacerbation rates of asthma using benralizumab
RU2728578C2 (ru) * 2013-08-12 2020-07-30 Астразенека Аб Способы нормализации симптомов астмы с применением бенрализумаба
WO2015057668A1 (en) * 2013-10-15 2015-04-23 Medimmune, Llc Methods for treating chronic obstructive pulmonary disease using benralizumab
CA2926089C (en) * 2013-10-24 2022-08-30 Medimmune, Llc Stable, aqueous antibody formulations
TW202110479A (zh) * 2019-05-16 2021-03-16 瑞典商阿斯特捷利康公司 使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法
TW202126688A (zh) * 2019-09-27 2021-07-16 瑞典商阿斯特捷利康公司 使用貝那利珠單抗治療遲發性氣喘之方法
TW202214692A (zh) * 2020-06-05 2022-04-16 瑞典商阿斯特捷利康公司 治療患有鼻瘜肉的患者的重度氣喘之方法
WO2026053166A1 (en) * 2024-09-06 2026-03-12 Medimmune Limited Anti-il5r-alpha treatment for acute exacerbations of asthma and copd

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2233974T3 (es) 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US6746839B1 (en) * 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
CA2704600C (en) 1999-04-09 2016-10-25 Kyowa Kirin Co., Ltd. A method for producing antibodies with increased adcc activity
US7404953B2 (en) 2000-02-15 2008-07-29 Kyowa Hakko Kogyo Co., Ltd. Methods using eosinophil-specific apoptosis inducer
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US7662925B2 (en) 2002-03-01 2010-02-16 Xencor, Inc. Optimized Fc variants and methods for their generation
WO2005035583A1 (ja) 2003-10-08 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. Ｉｌ－５受容体に特異的に結合する抗体組成物
US20060014680A1 (en) 2004-07-13 2006-01-19 Caiding Xu Peptides and compounds that bind to the IL-5 receptor
WO2007041635A2 (en) 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
MX376656B (es) * 2007-05-14 2025-03-07 Kyowa Kirin Co Ltd Metodos para reducir niveles de basófilos.
RU2383345C1 (ru) * 2008-08-07 2010-03-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") Способ лечения больных бронхиальной астмой
RU2578468C2 (ru) * 2010-12-16 2016-03-27 Дженентек, Инк. Способы диагностики и лечения, связанные с ингибированием th2
CN102544908B (zh) 2010-12-17 2016-01-06 富士康(昆山)电脑接插件有限公司 电连接器组件及插头连接器
WO2012158954A1 (en) * 2011-05-18 2012-11-22 Medimmune, Llc Methods of diagnosing and treating pulmonary diseases or disorders
US20140328839A1 (en) 2011-11-01 2014-11-06 Medlmmune, Llc Methods For Reducing The Frequency And Severity Of Acute Exacerbations Of Asthma
RU2728578C2 (ru) * 2013-08-12 2020-07-30 Астразенека Аб Способы нормализации симптомов астмы с применением бенрализумаба
AU2014306956B2 (en) 2013-08-12 2019-11-21 Astrazeneca Ab Methods for reducing exacerbation rates of asthma using benralizumab

Also Published As

Publication number Publication date
WO2015023507A8 (en) 2015-09-24
PL3033104T3 (pl) 2019-09-30
CN105451769A (zh) 2016-03-30
RU2016108809A3 (cg-RX-API-DMAC7.html) 2018-06-18
LT3033104T (lt) 2019-06-25
AU2014306959B2 (en) 2019-11-21
HUE043497T2 (hu) 2019-08-28
SMT202100152T1 (it) 2021-05-07
JP2020125304A (ja) 2020-08-20
JP2016527325A (ja) 2016-09-08
ME03403B (me) 2020-01-20
CN111588849A (zh) 2020-08-28
HK1225300A1 (en) 2017-09-08
JP2022120010A (ja) 2022-08-17
BR112016002317A2 (pt) 2017-12-12
LT3520811T (lt) 2021-03-25
RS58711B1 (sr) 2019-06-28
SI3520811T1 (sl) 2021-04-30
PL3520811T3 (pl) 2021-08-02
DK3520811T3 (da) 2021-03-22
RU2016108809A (ru) 2017-09-18
WO2015023507A3 (en) 2015-04-09
TR201907907T4 (tr) 2019-06-21
HRP20190920T1 (hr) 2019-07-12
JP6746496B2 (ja) 2020-08-26
SMT201900311T1 (it) 2019-07-11
EP3033104A2 (en) 2016-06-22
EP3875487A1 (en) 2021-09-08
EP4579236A3 (en) 2025-09-17
EP3520811A1 (en) 2019-08-07
US9441046B2 (en) 2016-09-13
HK1222559A1 (zh) 2017-07-07
HUE053627T2 (hu) 2021-07-28
KR102337599B1 (ko) 2021-12-10
BR112016002317A8 (pt) 2018-06-12
CY1124399T1 (el) 2022-07-22
EP3033104A4 (en) 2017-03-22
EP4636400A3 (en) 2025-12-24
EP3033104B1 (en) 2019-04-03
SI3033104T1 (sl) 2019-06-28
ES2866426T3 (es) 2021-10-19
PT3033104T (pt) 2019-06-27
MX2016001384A (es) 2016-08-03
US20150044203A1 (en) 2015-02-12
AU2020201277A1 (en) 2020-03-12
ES2733602T3 (es) 2019-12-02
RU2703568C2 (ru) 2019-10-21
CY1122033T1 (el) 2020-10-14
CA2917603C (en) 2023-05-16
CA2917603A1 (en) 2015-02-19
RS61565B1 (sr) 2021-04-29
EP4636400A2 (en) 2025-10-22
KR20160043049A (ko) 2016-04-20
WO2015023507A2 (en) 2015-02-19
AU2014306959A1 (en) 2016-02-04
EP3520811B1 (en) 2020-12-30
HRP20210406T1 (hr) 2021-04-30
MX381102B (es) 2025-03-12
MX2021003826A (es) 2021-05-27
SG11201600483QA (en) 2016-02-26
EP4579236A2 (en) 2025-07-02
JP2024129140A (ja) 2024-09-26
PT3520811T (pt) 2021-03-15

Similar Documents

Publication Publication Date Title
DK3512197T3 (da) Fremgangsmåde til kortlægning af intraprædikationsmodus
DK2906696T3 (da) Fremgangsmåder til modulering af c9orf72-ekspression
DK3225604T3 (da) Fremgangsmåde til fremstilling af flerlagsruder
DK3545906T3 (da) Indretning til udskiftning af hjerteklap
DK3079836T3 (da) Fremgangsmåder til fremstilling af effektlag
DE112013000673T8 (de) Filtervorrichtung
BR112014028487A2 (pt) braçadeira
DK3033104T3 (da) Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab
EP2911230A4 (en) CELL
DK2849760T3 (da) Fremgangsmåder til oligonukleotid-chelatkompleks
DK3065790T3 (da) Fremgangsmåder til fjernelse af alpha-galactose
DK2986308T3 (en) Angiotensin ii i kombination til behandlingen af hypotension
DK2870252T3 (da) Fremgangsmåder ved anvendelse af patatin
DK2983680T3 (da) Forbedring af organer til transplantation
HRP20190123T1 (hr) Postupak pročišćavanja saponina
EP2838629A4 (en) EXTRACTOR
EP2833184A4 (en) BINOCULARS
DK2809782T3 (da) Forbedret fremgangsmåde til fremstilling af makrokugler
DK3536339T3 (da) Fremgangsmåde til forbedring af astmasymptomer ved anvendelse af benralizumab
DK2925854T3 (da) Fremgangsmåde til forbedring af gærstammer
DK2872536T3 (da) Fremgangsmåde til ekstraktion af biomasse
BR112014032413A2 (pt) tanque
EP2811327A4 (en) lens
FI20135815L (fi) Teline
EP2897218A4 (en) KOMBINATOR